All companies
Visit website
SUNNY
OperatingMenstrual Mates, Inc.
Healthcare · Founded 2021
Ingenious period cup and applicator that is a 'total game changer for period care'
Valuation cap ⓘ
$7.0M
As of Apr 2025 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$61,050
Across 2 rounds since 2023
Financials
FY2021–FY2025 · from SEC filings · hover any figure for its source$627
−$60K
2021
$2K
−$455K
2022
$118K
−$1.1M
2023
$2K
−$455K
2024
$118K
−$1.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$627
$2,131
$117,809
$2,131
$117,809
Cost of goods sold
$542
$1,407
$44,266
$1,407
$44,266
Gross margin
14%
34%
62%
34%
62%
Net income
-$59,839
-$454,992
-$1,088,064
-$454,992
-$1,088,064
Taxes paid
$0
$8,932
$36,255
$8,932
$36,255
Balance sheet
Cash
$101,757
$1,207,853
$65,295
$1,207,853
$65,295
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$102,368
$1,676,229
$1,452,162
$1,676,229
$1,452,162
Short-term debt
$857
$560,955
$825,448
$560,955
$825,448
Long-term debt
$70,000
$1,538,755
$2,138,259
$1,538,755
$2,138,259
Total liabilities
$70,857
$2,099,710
$2,963,707
$2,099,710
$2,963,707
Other
Headcount
—
5
2
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.0M
Valuation cap
$7.0M
Valuation cap
SUNNY Convertible Note 1
Reg CF Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $0 / $63.2KValuation cap $7M
Raised $61.1K / $124KInvestors 19Valuation cap $7M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 3 annual reports (FY2023–FY2025)
19 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001990587
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.